Revascularbio

Suita, JP · 1 known investors

Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders. The company targets intractable diseases with angiogenic therapy, angiocrine therapy, and protein production platforms.

BiotechDeep TechMedical Devices